Companies · Medical Devices

Pace Surgical, Inc.

MALVERN · Medical Devices · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Pace Surgical, Inc. — recommendation, valuation, rhythm, risks.
$4.9M
Total raised · real
5
Rounds
0.4×
Latest step-up
Top 34%
Sector rank · raised
Seed
Latest stage · inferred · Wed Dec 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Pace Surgical, Inc. looks over-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the medical devices sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.95× the median modeled value of Seed Medical Devices companies in 2025–2027 (8 peers) — value vs value, same stage and era.
Active
  • Last raise 6 mo ago; this sector typically re-raises about every 16 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Medical Devices

Pace Surgical, Inc. is one of 233 Medical Devices companies tracked from MALVERN. By capital raised it ranks mid-pack (ahead of 67% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

medical-devices

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2023
Year incorporated
2025-12-17
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$2.5M$5.0M$7.5M$10MPre-Seed · 2023-08-07 Raised $400K (real) Modeled valuation $2.8M (est)$400K$2.8MPre-Seed2023Pre-Seed · 2024-02-20 Raised $1.0M (real) Modeled valuation $5.3M (est)$1.0M$5.3MPre-Seed2024Pre-Seed · 2024-09-16 Raised $765K (real) Modeled valuation $3.0M (est)$765K$3.0MPre-Seed2024Seed · 2025-07-07 Raised $1.2M (real) Modeled valuation $3.5M (est)$1.2M$3.5MSeed2025Seed · 2025-12-17 Raised $1.5M (real) Modeled valuation $3.4M (est)$1.5M$3.4MSeed2025Pre-Seed · 2025-12-17 Raised $600K (real) Modeled valuation $1.2M (est)$600K$1.2MPre-Seed2025+$1.0M+$765K+$1.2M+$1.5M+$600KCumulative $5.5M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$400K · 2023
Pre-Seed extension$1.0M · 2024
Pre-Seed extension$765K · 2024
Seed$1.2M · 2025
Seed extension$1.5M · 2025
Bridge · Seed-stage$600K · 2025smaller follow-on

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$3.4M
Base estimate est.
$1.2M
Conservative case
$6.2M
Upside case
$7.4M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the medical devices sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $2.8M · 2023-08-072023Pre-Seed · modeled $5.3M · 2024-02-20Pre-Seed · modeled $3.0M · 2024-09-16Seed · modeled $3.5M · 2025-07-07Seed · modeled $3.4M · 2025-12-17Pre-Seed · modeled $1.2M · 2025-12-172025
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
36%
Survival probability
16% low · 56% high
1.59×/yr
Annual markup
2.09×/yr upside case
0.5 yr
Elapsed time used
0.5 yr actual, capped for stale marks
medical devices
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
6 mo
Avg between rounds
$2.1M/yr
Capital velocity
2.9 yr
On record since
2023
First round
6
Rounds on file
How it compares to the market

Benchmarked against 233 companies in Medical Devices. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 1.9× above median
This company$4.9M
Sector median$2.6M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.5× of median
This company$600K
Sector median$1.3M
Modeled value — vs sector median (estimate, all stages) 0.2× of median
This company$3.4M
Sector median$15.4M

Raised more than 67% of sector peers (real $). Modeled value above 31% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #2 of 8.

This companyCohort peer
$100K$1.0M$10.0M$1.0M$10.0MCapital raised (log)Rose Diagnostics Inc. · Seed Raised $3.3M · modeled $7.2M (est)MemorialCare Surgical Center at Saddleback, LLC · Seed Raised $3.9M · modeled $2.4M (est)Intu Diagnostics · Seed Raised $1.2M · modeled $2.2M (est)Persperion Diagnostics Inc. · Seed Raised $4.4M · modeled $1.4M (est)Origami Surgical Inc. · Seed Raised $6.8M · modeled $1.3M (est)Danbury Surgical Center Lp · Seed Raised $6.2M · modeled $690K (est)North Dallas Surgical Center, LLC · Seed Raised $2.9M · modeled $339K (est)Pace Surgical, Inc. (this company) Raised $4.9M · modeled $3.4M (est)Pace Surgical, Inc.
CompanyStageRaised · realValue · estvs peer med.
Rose Diagnostics Inc.Seed$3.3M$7.2M4.09×
Pace Surgical, Inc. this companySeed$4.9M$3.4M1.95×
MemorialCare Surgical Center at Saddleback, LLCSeed$3.9M$2.4M1.36×
Intu DiagnosticsSeed$1.2M$2.2M1.22×
Persperion Diagnostics Inc.Seed$4.4M$1.4M0.78×
Origami Surgical Inc.Seed$6.8M$1.3M0.72×
Danbury Surgical Center LpSeed$6.2M$690K0.39×
North Dallas Surgical Center, LLCSeed$2.9M$339K0.19×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$400K2023-08-07$2.2M$2.8M90%
Pre-Seed$1.0M2024-02-20$5.6M$5.3M90%
Pre-Seed$765K2024-09-16$4.3M$3.0M90%
Seed$1.2M2025-07-07$6.1M$3.5M90%
Seed$1.5M2025-12-17$7.4M$3.4M90%
Pre-Seed$600K2025-12-17$3.3M$1.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$400K2023-08-07
    • First recorded raise — entered as Pre-Seed.
    • 1 investor on this round.
  2. Pre-Seed$1.0M2024-02-20
    • Came back fast: 6 mo vs the ~16 mo sector norm.
    • Round 2.5× larger than the prior — scaling up.
    • 1 investor on this round.
  3. Pre-Seed$765K2024-09-16
    • Came back fast: 7 mo vs the ~16 mo sector norm.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 10 investors on this round.
  4. Seed$1.2M2025-07-07
    • Came back fast: 10 mo vs the ~16 mo sector norm.
    • Round 1.6× larger than the prior — scaling up.
    • 15 investors on this round.
  5. Seed$1.5M2025-12-17
    • Came back fast: 5 mo vs the ~16 mo sector norm.
    • Round roughly the size of the prior one.
    • 11 investors on this round.
  6. Pre-Seed$600K2025-12-17
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.5× smaller than the prior — bridge or down round.
    • 1 investor on this round.
Intelligence
2026 ~Q2
Modeled next raise · ~6mo cadence
$600K
Modeled next size est.range $600K$960K
0.4×
Last step-up
$2.1M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Jeffrey F. O'Donnell, Sr.4 other2023-08
Jeffrey F. O'Donnell, Jr.3 other2023-08
William Scott Rhoda3 other2023-08
William John Odenthal2 other2023-08
Harry Thomas Hall, IV1 other2025-07
Nicholas F. Pachuda1 other2024-02
Jeffery F. O'Donnell, Jr.2025-07
Michael F. West2024-02
Michael Scott West2024-09
Nicholas Scott Pachuda2024-09
Nicholas Thomas Pachuda2025-07
Registry & provenance

Pace Surgical, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1987157
SEC CIK
2023
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Toetal Solutions, Inc.Other Health CareSeed$4.7M$3.5Mnetwork5 shared operators · same stage
Waypoint Orthopedics, Inc.Other Health CareSeed$3.6M$640Knetwork4 shared operators · same stage
Crossover Medical, Inc.HealthtechPre-Seed$500K$961Knetwork4 shared operators
Sense Diagnostics, Inc.Medical DevicesSeed$4.7M$6.5Msame sector · same stage
Bluejay Diagnostics, Inc.Medical DevicesSeed$4.7M$25.4Msame sector · same stage
Empowered Diagnostics, LLCMedical DevicesSeed$4.7M$27.8Msame sector · same stage
Kantum Diagnostics, Inc.Medical DevicesSeed$5.3M$65.7Msame sector · same stage
Persperion Diagnostics Inc.Medical DevicesSeed$4.4M$1.4Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Smart Step Surgical LLCMedical DevicesPre-Seed$1.7M84%
SafeOp Surgical, Inc.Medical DevicesSeries A$136.4M84%
Spinal Surgical Strategies, Inc.Medical DevicesPre-Seed$23.4M83%
IC Surgical, Inc.Medical DevicesPre-Seed$5.5M83%
National Surgical Partners, LLCMedical DevicesSeries A$30.2M83%
Surgical Safety Technologies Inc.Medical DevicesSeries B$70.3M83%
Tally Surgical, Inc.Medical DevicesSeries A$38.8M83%
OnPoint Surgical, Inc.Medical DevicesPre-Seed$7.4M83%
Frequently asked
How much funding has Pace Surgical, Inc. raised?
Pace Surgical, Inc. has raised approximately $4.9M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Pace Surgical, Inc.'s estimated valuation?
Provath's modeled valuation for Pace Surgical, Inc. is approximately $3.4M (modeled range $1.2M–$6.2M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Pace Surgical, Inc. at?
Pace Surgical, Inc.'s latest modeled financing stage is Seed. Its most recent recorded round closed around Wed Dec 17.
What does Pace Surgical, Inc. do and where is it based?
Pace Surgical, Inc. operates in the Medical Devices sector, based in MALVERN.
Explore related

See where Pace Surgical, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Pace Surgical, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.